Trial Details
TERMINATEDBasic Information
| Clinical ID | c1392 |
|---|---|
| Identifier | NCT02520284 |
| Trial Title | Safety and Efficacy of Andecaliximab (GS-5745) in Adults With Moderately to Severely Active Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | BIOLOGICAL: Andecaliximab|BIOLOGICAL: Placebo |
Participant Information
| Sponsor | Gilead Sciences |
|---|---|
| City | Dothan |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2|PHASE3 |
Time Information
| Start Date | 2025-09-15 |
|---|---|
| Primary Completion Date | 2025-09-16 |
| Completion Date | 2025-11-16 |